Stock Price & Volume | Full Chart
No headlines found.
Abeona Therapeutics Announces New Employee Inducement Grants
Globe Newswire (Fri, 24-Mar 7:30 AM ET)
Abeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting
Globe Newswire (Thu, 16-Mar 7:30 AM ET)
Abeona Therapeutics Announces Update on AAV Ophthalmology Program
Globe Newswire (Tue, 14-Mar 7:30 AM ET)
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.
Abeona Therapeutics trades on the NASDAQ stock market under the symbol ABEO.
As of March 27, 2023, ABEO stock price climbed to $2.72 with 68,958 million shares trading.
ABEO has a beta of 1.38, meaning it tends to be more sensitive to market movements. ABEO has a correlation of 0.12 to the broad based SPY ETF.
ABEO has a market cap of $46.72 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ABEO stock traded as high as $94.75 and as low as $2.19.
The top ETF exchange traded funds that ABEO belongs to (by Net Assets): VTI, VXF, DFAS, ITOT.
ABEO has underperformed the market in the last year with a price return of -62.5% while the SPY ETF lost -10.6%. However, in the short term, ABEO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.4% vs +3.9% return in SPY. But in the last 2 weeks, ABEO shares have been beat by the market, returning +1.1% compared to an SPY return of +3.1%.
ABEO support price is $2.51 and resistance is $2.91 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABEO stock will trade within this expected range on the day.